Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

The C-CAT tool helps assess and improve treatment for central centrifugal cicatricial alopecia.

Blocking CISD1 reduces hearing loss from cisplatin in mice.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Using cetirizine on the skin and taking vitamin D can help increase hair growth in children with hair loss from ectodermal dysplasia.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

Mutant CDP/Cux protein causes hair defects and reduced male fertility in mice.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

JAK inhibitors show promise for treating various skin diseases.

A patient got a skin reaction on their hands and feet after using secukinumab for psoriasis.

Baricitinib may effectively treat sudden hair whitening and regrowth in some cases.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

Cinnamomi cortex may help treat prostate enlargement by reducing related proteins.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Topical corticosteroids can cause serious side effects like Cushing's syndrome and hirsutism.

Topical cyclosporin promotes hair growth.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Diane® is an effective contraceptive that also helps treat acne and mild hair growth issues.

Apraglutide and N-acetylcysteine (NAC) show promise in reducing cytarabine's harmful effects on organs.

Budesonide alone is less effective than standard treatment for autoimmune hepatitis.